Literature DB >> 9103209

Histological grading and staging of IgA nephropathy.

H Shigematsu1.   

Abstract

More than 25 years have passed since immunoglobulin A (IgA) nephropathy was introduced as a disease entity independent of glomerulonephritis. It has been known that more than 30% of cases have gone into end-stage renal failure within 20 years, indicating the presence of a chronic active group in this disease. Histologically this disesase is composed of at least three types of tissue damage: (i) minimal inflammation including deposition of IgA-containing substances with minor matricial increase; (ii) acute lesions characterized by matricial damage of glomerular basement membrane (membranolysis) and/or mesangial matrix (mesangiolysis) with inflammatory cell accumulation and/or intrinsic cell proliferation; and (iii) chronic lesions mainly composed of postinflammatory sclerosis. The progression is actually accelerated by the frequency of acute lesions, resulting in increased glomerular sclerosis foci. In such a situation, the histologic grading and staging (G-S) system is proposed, with the aim of having a more precise understanding of the disease process. The histological grade (G) is estimated by the extent of acute glomerular and tubulointerstitial lesions, and the stage (S) is evaluated by the increase of extracellular matrices of the glomeruli and interstitial fibrosis. The evaluation of G and S is expressed semiquantitatively for more helpful clinical use.

Entities:  

Mesh:

Year:  1997        PMID: 9103209     DOI: 10.1111/j.1440-1827.1997.tb04480.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  9 in total

1.  A case of IgA nephropathy with deep venous thrombosis in the mesentery and lower extremities.

Authors:  Hong Tang; Lei Zhang; Wei Zhao; Rongquan Chen; Min Xie
Journal:  Quant Imaging Med Surg       Date:  2018-12

2.  The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takayuki Katsuno; Sawako Kato; Takahiro Imaizumi; Takaya Ozeki; Manabu Hishida; Takanobu Nagata; Masahiko Ando; Naotake Tsuboi; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2017-03-27       Impact factor: 2.801

3.  Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.

Authors:  Rin Asao; Katsuhiko Asanuma; Fumiko Kodama; Miyuki Akiba-Takagi; Yoshiko Nagai-Hosoe; Takuto Seki; Yukihiko Takeda; Isao Ohsawa; Satoshi Mano; Kiyoshi Matsuoka; Hiroyuki Kurosawa; Shinya Ogasawara; Yoshiaki Hirayama; Sakari Sekine; Satoshi Horikoshi; Masanori Hara; Yasuhiko Tomino
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

4.  Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy.

Authors:  Refik Kayali; Jin-Mo Ku; Gregory Khitrov; Michael E Jung; Olga Prikhodko; Carmen Bertoni
Journal:  Hum Mol Genet       Date:  2012-06-12       Impact factor: 6.150

5.  Urinary Podocyte Biomarkers and Glomerular Histologic Change.

Authors:  Kazunori Inoue
Journal:  Kidney360       Date:  2022-01-20

6.  Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis.

Authors:  Sekiko Taneda; Kazuho Honda; Keiko Uchida; Kosaku Nitta; Wako Yumura; Hideaki Oda; Michio Nagata
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

7.  Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.

Authors:  Jae Ryung Shin; Seung Min Kim; Jung Sun Yoo; Ji Yoon Park; Seul Ki Kim; Joo Hee Cho; Kyung Hwan Jeong; Tae Won Lee; Chun Gyoo Ihm
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

8.  Significance of urinary full-length megalin in patients with IgA nephropathy.

Authors:  Takuto Seki; Katsuhiko Asanuma; Rin Asao; Kanae Nonaka; Yu Sasaki; Juan Alejandro Oliva Trejo; Hiroyuki Kurosawa; Yoshiaki Hirayama; Satoshi Horikoshi; Yasuhiko Tomino; Akihiko Saito
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

9.  Shenhua Tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis.

Authors:  Wenjia Geng; Ribao Wei; Shuwen Liu; Li Tang; Hanyu Zhu; Pu Chen; Jie Wu; Xueguang Zhang; Fei Zhu; Zhong Yin; Xiangmei Chen
Journal:  Biol Res       Date:  2016-03-11       Impact factor: 5.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.